HomeFUNDING
FUNDING
Medical device and diagnostics companies are always looking for ways to improve their products and services. In the ever-changing landscape of the healthcare industry, it’s essential for these companies to stay ahead of the curve. That’s why funding is always news.
Series A, B, and other rounds of funding are essential for medical device and diagnostics companies. They provide the necessary capital to help these businesses grow and innovate. And with so many investors interested in this space, there are plenty of opportunities for companies to secure the funding they need.
AppliedVR Raises $36 Million Series B
AppliedVR said the round, which included investments from F-Prime Capital, JAZZ Venture Partners, Sway Ventures and SVB Ventures, set up AppliedVR for rapid growth as it prepares for its decision from the FDA on its first de novo submission.
Imbed Biosciences Wins a $2M Award From the U.S. Army to Prevent Combat Wound Infections
This competitive award was made in response to a solicitation from the U.S. Army seeking prototype solutions that prevent warfighter wound infections close to the point of injury without requiring evacuation to higher roles of care, and that enable speedy return of warfighters to duty.
Philips Receives Grant to Improve Quality & Accessibility of Maternal Care in Low & Middle Income Countries
USD 15.4 million grant from the Bill & Melinda Gates Foundation adds to Philips’ R&D investments and will boost obstetrics app development for Philips Handheld Ultrasound – Lumify
Sirona Medical Secures $40M in Series B Funding
The investment, led by GreatPoint Ventures, will fuel the commercialization of Sirona's platform, poised to transform radiology IT
HAPPE Spine Announces Close Of $3.35 Million Round In Series A Investment
The oversubscribed funding was led by strategic investors from within the spine industry along with prominent and continuing investment by the Genesis Innovation Group's cultivate(MD) Seed II Fund.
Gyroscope Announces Sanofi Equity Investment of up to $60 Million
The investment further validates the potential of Gyroscope’s gene therapy GT005 for the treatment of Geographic Atrophy, one of the world’s leading causes of blindness, and supports its ongoing Phase II development programs.
Biolinq Raises $100 Million, Unveils Micro-Sensing Technology in the Skin
This record private capital raise in the continuous glucose monitoring space includes participation from T&W Medical, AXA IM Alts, Global Health Investment Corporation, Ascensia Diabetes Care, Longevity Vision Fund, Falcon Edge Capital, Aphelion Capital, M Ventures, Hikma Ventures, Senvest, The Broe Group, Taisho Pharmaceutical, Cirrus Logic, EOFlow, Able Partners and the JDRF T1D Fund.
LightForce Orthodontics Secures $50 Million Series C Funding
“LightForce’s innovative approach to an industry that has lacked technological disruptiveness for the past 25 years is what initially attracted us to this investment opportunity,” said Wen Hsieh, partner, Kleiner Perkins.
New View Surgical, Inc. Closes $9M Series B Financing
The round was led by members of New York Angels with Corza Medical, Inc., IAG Capital Partners, Charleston Angels Partners, Ariel Savannah Angel Partners, Keiretsu Forum, Mid Atlantic Bio Angels (MABA) and SSIP, among others participating in the round.
